Influence of neprilysin inhibition on the efficacy and safety of empagliflozin in patients with chronic heart failure and a reduced ejection fraction: the EMPEROR-Reduced trial

AIMS: We evaluated the influence of sacubitril/valsartan on the effects of sodium-glucose cotransporter 2 (SGLT2) inhibition with empagliflozin in patients with heart failure and a reduced ejection fraction. METHODS AND RESULTS: The EMPEROR-Reduced trial randomized 3730 patients with heart failure a...

Descripción completa

Detalles Bibliográficos
Autores principales: Packer, Milton, Anker, Stefan D, Butler, Javed, Filippatos, Gerasimos, Ferreira, Joao Pedro, Pocock, Stuart J, Rocca, Hans-Peter Brunner-La, Janssens, Stefan, Tsutsui, Hiroyuki, Zhang, Jian, Brueckmann, Martina, Jamal, Waheed, Cotton, Daniel, Iwata, Tomoko, Schnee, Janet, Zannad, Faiez
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Fast Track Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878011/
https://www.ncbi.nlm.nih.gov/pubmed/33459776
http://dx.doi.org/10.1093/eurheartj/ehaa968

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878011/
https://www.ncbi.nlm.nih.gov/pubmed/33459776
http://dx.doi.org/10.1093/eurheartj/ehaa968

Ejemplares similares